Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
IQAI / Iq-ai seems I wrote too soon!
I like H&W's prospects given how low the mkt cap of the company is (£25m), at 10 times it is only £250m and babcoock is valued at £1.4b. Now, I am not saying they will be there in a couple of weeks but I can see a potential for 5-10 bagger in 24-36 months if thinks go their way. and it looks to me as they have cash flow to update and modernise the yards then labour costs become less influential on costs. Coupled with a UK govt that is desperate to get some sort of positive headlines of a "Great British" success story and there are a lot of, unrelated to ship building, but key factors that could play into them winning future orders.
Early days of course but the risk reward looks good to me (and I am not referring to the chart). Made a further 4 purchases this week including 2 today. Dyor etc etc
Wyn, interesting and unusual u take off ur TA hat off to FA. I agree, HARL has great potential to become big, but I am a bit concerned with the lack of IIs, if look at the shareholders, the only ones remaining are selling.. I am puzzled as to why big investors are not flocking to this what seems to be an amazing opportunity. A company that is valued at $25m.. with almost a billion dollar deal. What puzzles me further is why are the sellers Killik, Appledore and Kave offloading millions of shares at this low price if this opportunity is so so great. And why no big investors taking them. It is very very strange to me. Why u purchase 2x today? Why not tomorrow?
CI, well it looks to be holding around these levels so I think it might have bottomed out.
If the SP is to go up then my "logic" on the selling is that they are cashing in on the big rise from around 5p (they have been selling down from 24p), the big order is spread over several years and does not initself make the company but the investment will modernise the yard very quickly and I think further orders will come and there will be a snowball effect.
I have no idea if any of this will come to pass but the risk reward looks worth the punt. Imagine if it become a half billion or billion £ company! (Thats rampy for me!! :0))
Seems both my posts were correct! Just received Orphan status in the US.
QAI / Iq-ai seems I wrote too soon!
ReplyRecommendReport Post
D-Geeman
Posts: 3,714
Price: 0.00
No Opinion
RE:
IQAI / Iq-ai seems to be bubbling a little.
Ring any bells wyn?
'Drs. Chitambar and Kathleen Schmainda, PhD, discovered that gallium maltolate (GaM) significantly slowed the growth, and reduced the size, of glioblastoma.'
'GaM, originally developed by Harvard and Stanford educated scientist Lawrence R. Bernstein, PhD, is an orally available form of the metal gallium, which, in the body, shares many chemical properties with the highly oxidized form of iron, called Fe(III). Numerous studies examining the relationship between iron and cancer show that increased levels of iron in the body can be associated with increased cancer risk and severity, because cancer cells depend on iron to multiply and spread. Because of gallium’s similarity to Fe(III), it enters cancer cells instead of iron, preventing their multiplication.
“The discovery that GaM has anticancer activity against glioblastoma in pre-clinical studies is extremely exciting; it opens the door for developing it as a drug for treatment of glioblastoma in patients,” says Christopher Chitambar, MD, Emeritus Professor of Medicine and Biophysics, Division of Hematology and Oncology at MCW. “The anticancer mechanism of GaM applies to other solid tumors as well,” he adds.'
sorry D, I am not on your wavelength.. What am I missing?
'applies to other solid tumors as well,” he adds.''
Just thinking of combination therapies – or possible competition I suppose
Are you thinking that AVCT could buy them or be a candidate, for their DX business?
Reading the IQAI bb this was spotted on the FDA site in the morning by one poster, but not RNS'd till late afternoon, then generated 20+% rise in a few minutes
Missed opportunity for a quick profit!
I hadn't thought of that. But the two approaches would complement each other as a treatment for solid tumours; GaM slowing the growth while AVA6K picks off the cancer cells.
I think that the main man at IQAI (TB) is pretty ruthless and owns a lot of the shares himself, or the family do. It wouldn't be cheap.
I suppose it might fit well, and AI is hot technology. But there must be dozens of possibles....
'About Imaging Biometrics, LLC
IQ-AI Limited, (LON: IQAI) (OTCQB: IQAIF), the parent company of Wisconsin-based Imaging Biometrics, LLC (IB), is focused on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com.'